IRIS
BACCARANI, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.637
AS - Asia 9.849
EU - Europa 6.792
SA - Sud America 1.783
AF - Africa 249
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 10
Totale 41.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.297
SG - Singapore 4.760
CN - Cina 2.019
UA - Ucraina 1.682
DE - Germania 1.444
BR - Brasile 1.355
HK - Hong Kong 938
IT - Italia 920
VN - Vietnam 698
FI - Finlandia 626
RU - Federazione Russa 575
FR - Francia 432
IE - Irlanda 326
IN - India 303
TR - Turchia 255
GB - Regno Unito 237
SE - Svezia 192
CA - Canada 175
AR - Argentina 161
BD - Bangladesh 150
KR - Corea 138
MX - Messico 91
IQ - Iraq 87
EC - Ecuador 70
ID - Indonesia 68
ZA - Sudafrica 64
IR - Iran 56
NL - Olanda 55
PL - Polonia 55
JP - Giappone 52
PK - Pakistan 52
VE - Venezuela 52
CO - Colombia 50
ES - Italia 43
SA - Arabia Saudita 39
AT - Austria 35
BE - Belgio 34
PH - Filippine 34
CZ - Repubblica Ceca 32
KE - Kenya 29
MA - Marocco 29
EG - Egitto 28
PY - Paraguay 27
UZ - Uzbekistan 27
CL - Cile 25
PE - Perù 21
AE - Emirati Arabi Uniti 20
EU - Europa 20
TN - Tunisia 19
DZ - Algeria 18
JO - Giordania 16
TW - Taiwan 16
AZ - Azerbaigian 15
LT - Lituania 14
UY - Uruguay 14
MY - Malesia 13
CH - Svizzera 12
DO - Repubblica Dominicana 12
IL - Israele 11
PA - Panama 11
TG - Togo 11
CR - Costa Rica 10
GR - Grecia 10
JM - Giamaica 10
ET - Etiopia 9
NP - Nepal 9
TT - Trinidad e Tobago 9
AL - Albania 8
BG - Bulgaria 8
KZ - Kazakistan 8
AU - Australia 7
MD - Moldavia 7
OM - Oman 7
PS - Palestinian Territory 7
GE - Georgia 6
HR - Croazia 6
KG - Kirghizistan 6
LB - Libano 6
LV - Lettonia 6
AM - Armenia 5
BH - Bahrain 5
BO - Bolivia 5
CI - Costa d'Avorio 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
NG - Nigeria 5
TH - Thailandia 5
AO - Angola 4
GT - Guatemala 4
HU - Ungheria 4
NO - Norvegia 4
RO - Romania 4
RW - Ruanda 4
SN - Senegal 4
BS - Bahamas 3
CY - Cipro 3
EE - Estonia 3
LY - Libia 3
PT - Portogallo 3
RS - Serbia 3
Totale 41.285
Salva come PNG Salva come JPEG
Città #
Fairfield 2.736
Ashburn 1.989
Woodbridge 1.815
Singapore 1.786
Houston 1.320
Jacksonville 1.168
Chandler 1.137
Wilmington 1.085
Seattle 1.053
Cambridge 978
Beijing 955
Hong Kong 935
Ann Arbor 924
Dearborn 760
San Jose 690
Udine 486
Boardman 393
Los Angeles 357
Lauterbourg 331
Princeton 329
Dublin 325
Dallas 263
Ho Chi Minh City 240
Hefei 172
Izmir 171
Buffalo 157
San Diego 151
São Paulo 140
Hanoi 138
New York 131
Seoul 126
Chicago 124
Munich 121
Redondo Beach 111
The Dalles 107
Helsinki 86
Council Bluffs 79
Ogden 76
Mumbai 72
Des Moines 70
Ottawa 70
Dong Ket 69
Salt Lake City 64
Frankfurt am Main 59
Santa Clara 57
Norwalk 56
Orem 56
Milan 52
Nanjing 50
Kunming 47
Tokyo 45
Brooklyn 44
Rio de Janeiro 41
Denver 40
Warsaw 40
Chennai 37
Phoenix 37
London 35
Poplar 35
Washington 35
Guangzhou 34
Toronto 34
Düsseldorf 33
Baghdad 32
Brussels 32
Montreal 32
Haiphong 31
Da Nang 29
Porto Alegre 29
Turku 29
Augusta 28
Brasília 28
Elk Grove Village 28
Nuremberg 27
Quito 27
Johannesburg 26
Tampa 26
Nairobi 25
Pittsburgh 25
Redmond 25
Ankara 24
Boston 24
Mexico City 24
Stockholm 24
Belo Horizonte 23
Hyderabad 23
Jinan 23
Manchester 23
Pune 23
Rome 23
Tashkent 23
Atlanta 22
Leawood 22
Nanchang 21
Trieste 21
Dhaka 20
San Francisco 20
Grafing 19
Lahore 19
Amsterdam 18
Totale 26.075
Salva come PNG Salva come JPEG
Nome #
TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study 344
Appendiceal Mucinous Neoplasm (AMN); A Case Series and Literature Review 338
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 285
Which Type of Incision for Liver Transplantation? 255
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 244
ROLE OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS IN PATIENTS WITH DE NOVO COLON CANCER AFTER RENAL TRANSPLANTATION. 242
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 236
A single-center experience of late retransplantation of the liver. 232
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 225
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 206
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 200
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 200
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 198
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 195
A comparative prospective study of two available solutions for kidney and liver preservation 194
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 194
Differential proteomic analysis of hepatocellular carcinoma 193
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 193
Liver transplantation from old donors into HCV and non-HCV recipients 191
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 191
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 184
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 182
. Quantification of human livers as an effective source of hepatocytes for clinical application 181
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 180
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 179
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 178
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 177
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 175
Arterial rupture as the result of fungal arteritis after renal transplantation 174
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 174
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 173
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 172
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 171
Impact of new treatment options for hepatitis c virus infection in liver transplantation 171
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 170
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 170
Acute pancreatitis after kidney transplantation. 169
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 169
La splenectomia laparotomica e laparoscopica 166
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 166
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 166
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 166
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 166
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 165
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 165
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 164
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 163
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 161
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 161
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 160
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 159
Quality-of-life assessment before and after liver transplantation. 159
Donor safety in living donor liver donation: An Italian multicenter survey 159
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 158
Future of minimally invasive surgery 156
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 156
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 156
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 156
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 155
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 155
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 155
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 155
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 155
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 153
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 153
Appendicectomy and Crohn's disease: clinical and genetic associations 152
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 152
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 150
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 150
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 149
Differential Proteomic Analysis of Subfractioned Human Hepatocellular Carcinoma Tissues 149
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 149
Split and whole liver transplantation outcomes: A comparative cohort study 148
ELDERLY VERSUS YOUNG LIVER TRANSPLANT RECIPIENTS: PATIENT AND GRAFT SURVIVAL. 148
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 148
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 147
Transarterial chemoembolization does not harm the hepatic artery at transplantation 147
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 146
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 144
RENAL TRANSPLANTATION IN A PATIENT AFFECTED BY MOUNIER-KUHN SYNDROME 144
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 144
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 143
Application of a clinical score for the diagnosis of acute appendicitis in childhood: a retrospective analysis of 197 patients 142
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 142
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 142
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 142
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 142
A Simple Trick for Optimizing the Three-Vein Technique Outflow Anastomosis in Piggyback Liver Transplantation 141
DIAGNOSTIC, THERAPEUTIC AND EDUCATIONAL ASPECTS OF LAPAROSCOPIC CHOLANGIOGRAPHY 140
GRAFT VESSEL WALL PATHOLOGY IN A CASE OF HEPATIC ARTERY PSEUDO-ANEURYSM IN A LIVER TRANSPLANT RECIPIENT. 140
Right lobe living related graft loss due to intrahepatic multiple arterio-portal fistulas. 140
Intraoperative cholangiography in laparoscopic cholecystectomy during residency in general surgery 139
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 139
Gastrointestinal Perforations in Adult Whole-Liver Transplant Patients: Clinical, Radiologic, and Histopathologic Analysis 139
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 138
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression 138
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 138
Advancing transplantation: New questions, new possibilities in kidney and liver transplantation 138
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 138
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 137
Totale 17.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021753 0 0 0 0 0 0 0 0 0 0 515 238
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.588 358 212 41 335 233 701 6 170 337 30 70 95
2023/2024957 115 89 43 26 162 152 12 81 138 55 18 66
2024/20256.305 140 402 202 236 264 304 355 310 611 545 1.170 1.766
2025/202611.381 861 1.719 1.093 1.185 1.697 928 1.237 402 872 944 443 0
Totale 41.874